Recently, it has also been reported that osteoblast-derived soluble factors, including TGF-β, indeed promote metastatic potential in prostate cancer cells, and the effect by TGF-β is, at least partly, mediated by noncanonical TRAF6-dependent signaling [32]. Here, TGFB1 is linked to prostate cancer.